Market Trends of Antibiotics Industry
This section covers the major market trends shaping the Antibiotics Market according to our research experts:
Cephalosporins is Expected to Witness Considerable Growth Over the Forecast Period
Cephalosporins are a beta-lactam antibiotic that inhibits peptidoglycan synthesis in the bacterial cell wall. It manages a wide range of infections from gram-positive and gram-negative bacteria. These antibiotics commonly treat pneumonia, skin infections, ear infections, meningitis, upper respiratory tract infections, etc.
The first cephalosporin was discovered in 1945. With time, many advancements were made to improve the cephalosporin efficacy against various bacteria. Each upgrade was termed a generation. Currently, there are five generations of cephalosporins. Due to their broad applicability and flexible route of administration (oral or intravenous), cephalosporins are prescribed and used widely worldwide, which is the major driving factor for the segment. In addition, with the growing incidence of infection, the companies are evolving their product offerings, launching new ones, and adopting merger and acquisition strategies to develop new product lines. For instance, in October 2021, Novartis' subsidiary Sandoz acquired GlaxoSmithKline's (GSK) cephalosporin antibiotics business for USD 500 million. The transaction has granted Sandoz the rights to GSK's Zinnat, Zinacef, and Fortum brands, sold in more than 100 markets.
The high efficiency of cephalosporin in combating various infections is also expected to propel segment growth. For instance, according to the October 2021 NCBI research study, antibiotics use for COVID-19 patients has shown considerable therapeutic benefits. It is evident in patients with severe pneumonia and those receiving glucocorticoids or other immunosuppressant therapeutics. The study also stated ceftazidime and cefepime demonstrated good inhibitory activity toward COVID-19. It also concluded ceftazidime and cefepime repurposing are highly effective for moderate and severe COVID-19 patient symptomatic improvement.
Therefore, owing to these factors mentioned above, the cephalosporin segment is expected to witness considerable growth over the forecast period.
North America Expected to Witness Significant Growth Over the Forecast Period
North America is expected to dominate the antibiotics market over the forecast period. The growth is due to factors such as the high antibiotics demand and consumption in the region due to the high burden of infectious diseases and the growing aging population. For instance, according to the October 2022 CDC report, in 2021, more than 7,174 new cases of TB were reported in the US. The same source also noted that the prevalence of TB was to be highest among Hispanic or Latino persons, who accounted for about 30.0% of the total TB cases reported in the country. Thus, such a high prevalence of infectious diseases is expected to drive the demand for antibiotics in the region, thereby propelling market growth.
Key product launches, high concentration of market players or manufacturer's presence, acquisitions and partnerships among significant players, and the high prevalence of diseases in the US are some of the factors driving the growth of the antibiotics market in the country. For instance, according to the study published by researchers from the University of Missouri in October 2021, pneumonia was reported to be 24.8 cases per 10,000 adults in the United States. Similarly, according to the November 2021 article of the CDC, the common cold affects millions of people in the US each year. Adults have 2-3 colds yearly, and children get even more. Thus, due to the country's high burden of bacterial infectious diseases, the US is expected to hold a significant share of the antibiotics market in the North American region.
Therefore, the studied market growth is anticipated in the North America Region due to the aforementioned factors.
